AND	term1 AND term2	Both terms must be included
OR	term1 OR term2	Either term
NOT	term1 NOT term2	term2 must not appear
""	"term1 term2"	Exact match
()	term1 AND (term2 OR term3)	Grouping terms
?	withdr?w	Single letter wildcard (withdraw, withdrew)
*	withdr*	Multiple letter wildcard (withdraw, withdrawn, withdrawing)
"..."~n	"term1 term2"~n	Proximity (term1 within n words of term2)

Search results

Order by: most recent most popular relevance

Jurisdiction

Work area

Firm name

Date from

Date to

Results:1-10 of 1,486

Review of recent listings of biotechnology companies by way of Chapter 18A of the Hong Kong Main Board Listing Rules

King & Wood Mallesons
Hong Kong
September 28 2018

Since the new regime for listing of innovative companies was put in place four months ago, there has been a number of biotechnology companies seeking

Patents in Luxembourg

Marks & Clerk
Luxembourg, Global
September 21 2018

A structured guide to patents law and practice in Luxembourg

Surveying the CRISPR-Cas9 Patent Landscape in the United States

Gibbons PC
USA
August 20 2018

This post will discuss the patent landscape of the groundbreaking CRISPR-Cas9 systems in the United States, including pending legal disputes. A

Trump Administration Lifts Ban On Biotechnology Crops In Wildlife Refuges

Bergeson & Campbell PC
USA
August 17 2018

On August 2, 2018, the Trump Administration’s Principal Deputy Director of the U.S. Fish and Wildlife Service, Gregory J. Sheehan, reversed an Obama

AbbVie Files Suit Against Sandoz Alleging Infringement of Two Humira-Related Patents

Rothwell, Figg, Ernst & Manbeck, PC
USA
August 14 2018

On August 10, 2018, AbbVie, Inc. and AbbVie Biotechnology Ltd. (collectively “AbbVie”) sued Sandoz Inc., Sandoz GMBH, and Sandoz International GMBH

Life sciences: product regulation and liability in Turkey

NSN Law Firm
Turkey, Global
July 11 2018

A structured guide to product regulation and liability laws in Turkey

Innovation key to driving success in healthcare

Boult Wade Tennant LLP
USA, United Kingdom
July 3 2018

As the NHS turns 70, it is notable that the focus for the future is on innovation for the improvement of patient care. Technologies spanning genetic

PTAB Denies Another IPR Petition Relating to Adalimumab

Rothwell, Figg, Ernst & Manbeck, PC
USA
June 14 2018

The Patent Trial and Appeal Board (“PTAB”) recently denied Sandoz’s petition for inter partes review (“IPR”) of claims 1-30 of AbbVie’s patent, U.S

Capital Markets Alert - Public Market Advocacy Groups Release Guidance

Skadden Arps Slate Meagher & Flom LLP
USA
May 10 2018

On April 27, 2018, the Securities Industry and Financial Markets Association (SIFMA), the U.S. Chamber of Commerce and Nasdaq, along with certain

The Budget 2018-2019: our three key areas for intellectual property

King & Wood Mallesons
Australia
May 9 2018

Biotechnology companies and generic pharmaceuticals are the winners and celebrities are the Biggest Losers in some intellectual property-related

Search techniques

Current Search

Refine

Content type

Tags